INFINITY PHARMACEUTICALS, INC. Contracts & Agreements

Retention and Severance Protection Agreement between the Registrant and Lawrence Bloch dated as of March 29, 2023 (Filed With SEC on May 9, 2023)

Amended and Restated Development and License Agreement, dated as of December 24, 2012, by and between the Registrant and Intellikine, LLC (Filed With SEC on March 28, 2023)

Retention and Severance Protection Agreement between the Registrant and Adelene Perkins dated as of February 22, 2023 (Filed With SEC on March 28, 2023)

Retention and Severance Protection Agreement between the Registrant and Robert Ilaria dated as of February 22, 2023 (Filed With SEC on March 28, 2023)

Retention and Severance Protection Agreement between the Registrant and Stephane Peluso dated as of February 22, 2023 (Filed With SEC on March 28, 2023)

Retention and Severance Protection Agreement between the Registrant and Seth Tasker dated as of February 22, 2023 (Filed With SEC on March 28, 2023)

Amendment No. 1 to 2019 Equity Incentive Plan of Infinity Pharmaceuticals, Inc (Filed With SEC on March 29, 2022)

Offer Letter between the Registrant and Stephane Peluso, Ph.D., dated July 12, 2021 (Filed With SEC on November 2, 2021)

Offer Letter between the Registrant and Robert Ilaria, Jr., M.D., dated August 11, 2021 (Filed With SEC on November 2, 2021)

Amendment to Amended and Restated Capital on Demand Sales Agreement, dated July 29, 2019, by and among Infinity Pharmaceuticals, Inc. and JonesTrading Institutional Services LLC... (Filed With SEC on July 27, 2021)

Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on March 16, 2021)

Purchase Agreement, dated February 11, 2021, between Infinity Pharmaceuticals, Inc. and Piper Sandler & Co., as representative of the underwriters named therein (Filed With SEC on February 12, 2021)

Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on March 3, 2020)

Funding Agreement, dated January 8, 2020, by and among Infinity Pharmaceuticals, Inc., BVF Partners, L.P., and Royalty Security, LLC (Filed With SEC on March 3, 2020)

Novation and Amendment Agreement, dated January 27, 2020, by and among Infinity Pharmaceuticals, Inc., BVF Partners, L.P., Royalty Security, LLC, and Royalty Security Holdings, LLC (Filed With SEC on March 3, 2020)

2013 Employee Stock Purchase Plan, as amended (Filed With SEC on March 3, 2020)

Form of Stock Option Agreement under 2019 Equity Incentive Plan (Filed With SEC on July 30, 2019)

2013 Employee Stock Purchase Plan, as amended (Filed With SEC on July 30, 2019)

Amended and Restated Capital on Demand Sales Agreement, dated July 29, 2019, by and among Infinity Pharmaceuticals, Inc. and JonesTrading Institutional Services LLC and B. Riley... (Filed With SEC on July 30, 2019)

Capital on Demand Sales Agreement, dated June 28, 2019, by and between Infinity Pharmaceuticals, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on June 28, 2019)

Amendment No. 4 to Amended and Restated Development and License Agreement, dated as of March 4, 2019, by and between the Registrant and Intellikine LLC (Filed With SEC on May 7, 2019)

Purchase and Sale Agreement, dated as of March 5, 2019, between the Registrant and HealthCare Royalty Partners III, L.P (Filed With SEC on May 7, 2019)

Protective Rights Agreement, dated as of March 11, 2019, between the Registrant and HCR Collateral Managements, LLC (Filed With SEC on May 7, 2019)

Lease Agreement, dated April 3, 2019, between Registrant and Sun Life Assurance Company of Canada (Filed With SEC on May 7, 2019)

Offer Letter between the Registrant and Samuel Agresta, M.D., dated July 19, 2018 (Filed With SEC on November 5, 2018)

Amendment No. 1, dated August 3, 2018, to Infinity Pharmaceuticals, Inc. Executive Severance Benefits Plan (Filed With SEC on November 5, 2018)

Third Amendment to Amended and Restated Development and License Agreement, dated July 26, 2017, by and between the Registrant and Intellikine LLC (Filed With SEC on November 7, 2017)

Convertible Promissory Note, dated July 26, 2017, by and between Registrant and Intellikine LLC (Filed With SEC on November 7, 2017)

THIRD AMENDMENT OF LEASE (Filed With SEC on June 2, 2017)

SECOND AMENDMENT OF LEASE (Filed With SEC on May 22, 2017)

AMENDMENT OF LEASE (Filed With SEC on March 29, 2017)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on March 14, 2017)

AGREEMENT FOR TERMINATION OF LEASE AND VOLUNTARY SURRENDER OF PREMISES (Filed With SEC on March 14, 2017)

INFINITY PHARMACEUTICALS, INC. RESTRICTED STOCK AGREEMENT (Filed With SEC on March 14, 2017)

INFINITY PHARMACEUTICALS, INC. Nonstatutory Stock Option Agreement Inducement Grant Pursuant to NASDAQ Stock Market Rule 5635(c)(4) (Filed With SEC on March 14, 2017)

THIS IS AN IMPORTANT LEGAL DOCUMENT. PLEASE CONFER WITH A LAWYER OR OTHER TRUSTED ADVISOR BEFORE SIGNING THIS DOCUMENT. (Filed With SEC on March 14, 2017)

AMENDMENT No. 2 TO AMENDED AND RESTATED DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on November 9, 2016)

AMENDMENT NO. 6 TO 2010 STOCK INCENTIVE PLAN OF INFINITY PHARMACEUTICALS, INC. (Filed With SEC on May 4, 2016)

INFINITY PHARMACEUTICALS, INC. Shares of Common Stock (par value$0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on May 4, 2016)

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] (Filed With SEC on February 23, 2016)

INFINITY PHARMACEUTICALS, INC. 2010 STOCK INCENTIVE PLAN (Filed With SEC on June 16, 2015)

AMENDMENT TO AMENDEDAND RESTATED DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on November 10, 2014)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. COLLABORATION AND LICENSE AGREEMENT BY AND... (Filed With SEC on November 10, 2014)

FIRST AMENDMENT TO FACILITY AGREEMENT (Filed With SEC on November 10, 2014)

LEASE OF PREMISES AT784 MEMORIAL DRIVE CAMBRIDGE, MASSACHUSETTS FROM BHX, LLC, ASTRUSTEE OF 784 REALTY TRUST TO INFINITY PHARMACEUTICALS, INC. TABLE OF CONTENTS (Filed With SEC on November 10, 2014)

SEVENTH AMENDMENT TO LEASE (Filed With SEC on November 10, 2014)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. FACILITY AGREEMENT (Filed With SEC on May 6, 2014)

Warrant to Purchase Common Stock of InfinityPharmaceuticals, Inc. (Filed With SEC on May 6, 2014)

INFINITY PHARMACEUTICALS, INC. 2010 STOCK INCENTIVE PLAN (Filed With SEC on June 13, 2013)

INFINITY PHARMACEUTICALS, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on April 12, 2013)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on March 5, 2013)

FOURTH AMENDMENT TO SUBLEASE (Filed With SEC on March 5, 2013)

Infinity Pharmaceuticals, Inc. Executive Severance Benefits Plan (Filed With SEC on February 12, 2013)

INFINITY PHARMACEUTICALS, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on December 13, 2012)

INFINITY PHARMACEUTICALS, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on August 10, 2012)

SIXTH AMENDMENT TO LEASE (Filed With SEC on August 7, 2012)

FORM OF RELEASE OF CLAIMS (Filed With SEC on July 25, 2012)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 19, 2012)

TERMINATION AND REVISED RELATIONSHIP AGREEMENT (Filed With SEC on July 19, 2012)

FIFTH AMENDMENT TO LEASE (Filed With SEC on August 9, 2011)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. (Filed With SEC on August 4, 2010)

INFINITY PHARMACEUTICALS, INC. 2010 STOCK INCENTIVE PLAN (Filed With SEC on May 28, 2010)

INFINITY PHARMACEUTICALS, INC. Incentive Stock Option Granted Under 2010 Stock Incentive Plan (the Plan) (Filed With SEC on May 28, 2010)

INFINITY PHARMACEUTICALS, INC. Nonstatutory Stock Option Granted Under 2010 Stock Incentive Plan (the Plan) (Filed With SEC on May 28, 2010)

THIRD AMENDMENT TO SUBLEASE (Filed With SEC on May 6, 2009)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisksdenote omissions. (Filed With SEC on March 13, 2009)

INFINITY PHARMACEUTICALS, INC. SECOND AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on November 20, 2008)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 20, 2008)

LINE OF CREDIT AGREEMENT (Filed With SEC on November 20, 2008)

STOCK RESTRICTION AGREEMENT (Filed With SEC on November 5, 2008)

INFINITY PHARMACEUTICALS, INC. (Filed With SEC on March 14, 2008)

AMENDMENT NO. 4 TO INFINITY PHARMACEUTICALS, INC. (Filed With SEC on August 9, 2007)

INFINITY PHARMACEUTICALS, INC. (Filed With SEC on September 18, 2006)

Confidential Materials omitted and filed separately withthe Securities and Exchange Commission. Asterisks denote omissions. (Filed With SEC on September 18, 2006)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asteriskdenote omissions. COLLABORATION AND OPTION AGREEMENT by and between... (Filed With SEC on September 18, 2006)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. (Filed With SEC on September 18, 2006)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisksdenote omissions. COLLABORATION AGREEMENT (Filed With SEC on September 18, 2006)

MASTER LOAN AND SECURITY AGREEMENT No. 2081009 dated as of October 16, 2002(Agreement) (Filed With SEC on September 18, 2006)

MASTER SECURITY AGREEMENT dated as of December 6, 2002 (Agreement) (Filed With SEC on September 18, 2006)

MASTER LEASE AGREEMENT dated as of August 11, 2004 (Agreement) (Filed With SEC on September 18, 2006)

VENTURE LOAN AND SECURITY AGREEMENT (Filed With SEC on September 18, 2006)

Page 2 (Filed With SEC on September 18, 2006)

INFINITY PHARMACEUTICALS, INC. SAB CONSULTING AGREEMENT (Filed With SEC on September 18, 2006)

INFINITY PHARMACEUTICALS, INC. 2001 STOCK INCENTIVE PLAN (Filed With SEC on September 18, 2006)

Date of (Filed With SEC on September 18, 2006)

STOCK RESTRICTION AGREEMENT (Filed With SEC on September 18, 2006)

Date of (Filed With SEC on September 18, 2006)

RESTRICTED STOCK AGREEMENT (Filed With SEC on September 18, 2006)

Date of (Filed With SEC on September 18, 2006)

RESTRICTED STOCK AGREEMENT (Filed With SEC on September 18, 2006)

Date of (Filed With SEC on September 18, 2006)

Infinity Pharmaceuticals, Inc. Nonstatutory Stock Option Agreement (Filed With SEC on September 18, 2006)

STOCK RESTRICTION AGREEMENT (Filed With SEC on September 18, 2006)

AMENDMENT NO. 1 TO DISCOVERY PARTNERS INTERNATIONAL, INC. (Filed With SEC on September 18, 2006)

INFINITY PHARMACEUTICALS, INC. Incentive Stock Option Agreement (Filed With SEC on September 18, 2006)

INFINITY PHARMACEUTICALS, INC. Nonstatutory Stock Option Agreement (Filed With SEC on September 18, 2006)

Restricted Stock Agreement Granted Under 2000 Stock Incentive Plan, as amended (Filed With SEC on September 18, 2006)

LEASE AGREEMENT (Filed With SEC on September 18, 2006)

SUBLEASE (Filed With SEC on September 18, 2006)

OMNIBUS AMENDMENT TO RETENTION BONUS AGREEMENTS ANDCHANGE-IN-CONTROL AGREEMENTS OF CERTAINEXECUTIVE EMPLOYEES (Filed With SEC on September 11, 2006)

STOCK AND ASSET PURCHASE AGREEMENT (Filed With SEC on July 11, 2006)

ASSETPURCHASE AGREEMENT between: DiscoveryPartners International, INC., aDelaware corporation; and IRORIDISCOVERY, INC., aCalifornia corporation Effectiveas of October 7, 2005 (Filed With SEC on March 16, 2006)

EMPLOYMENT AGREEMENT (Filed With SEC on April 6, 2005)

DISCOVERYPARTNERS INTERNATIONAL, INC. Stock Issuance Grant Notice (2000 Stock Incentive Plan) (Filed With SEC on April 6, 2005)

DISCOVERY PARTNERS INTERNATIONAL,INC. STOCKISSUANCE AGREEMENT UNDER THE 2000 STOCKINCENTIVE PLAN (Filed With SEC on April 6, 2005)

CHANGE-IN-CONTROL AGREEMENT FOR CERTAIN EXECUTIVES OFDISCOVERY PARTNERS INTERNATIONAL, INC. (Filed With SEC on April 6, 2005)

SEPARATIONAGREEMENT (Filed With SEC on March 10, 2005)

FY Base Periods 1-5 Estimated Costs Option 04 Fixed Fee Estimated Cost Plus Fixed Fee 04 Period 1 (8/23/04 -12/23/04) [***] $ [***] [***] [***] 05 Period 2 (12/24/04-12/23/05)... (Filed With SEC on November 9, 2004)

PRICING SCHEDULE (Filed With SEC on August 6, 2004)

CHANGE-IN-CONTROLAGREEMENT FOR CERTAIN EXECUTIVES OF DISCOVERY PARTNERS INTERNATIONAL, INC. JULY2003 (Filed With SEC on August 13, 2003)

CHANGE-IN-CONTROLAGREEMENT FOR CERTAIN EXECUTIVES OF DISCOVERY PARTNERS INTERNATIONAL, INC. (Filed With SEC on August 13, 2003)

EmploymentAgreement (hereinafter referred to as ,,Agreement between Discovery Technologies Ltd. Gewerbestrasse 16 4123 Allschwil (hereinafter referred to als ,,DTL) and Urs... (Filed With SEC on April 30, 2003)

Amendment No. 3 to the 2002 Agreement between Discovery Partners International, Inc and Pfizer Inc (Filed With SEC on March 21, 2003)

Discovery Partners International, Inc. Amendment No. 1 to Notice of Grant of Stock Option (Filed With SEC on March 21, 2003)

GENERAL RELEASE AND SETTLEMENT AGREEMENT (Filed With SEC on March 21, 2003)

DISCOVERY PARTNERS INTERNATIONAL, INC. CONSULTING AGREEMENT (Filed With SEC on March 21, 2003)

STOCK PURCHASE AGREEMENT (Filed With SEC on March 21, 2003)

AMENDMENT NO. 1 TO RIGHTS AGREEMENT (Filed With SEC on March 21, 2003)

STOCK PURCHASE AGREEMENT (Filed With SEC on March 21, 2003)

EXHIBIT 99(A) (Filed With SEC on February 24, 2003)

FINANCIAL INFORMATION (Filed With SEC on November 14, 2002)

FINANCIAL INFORMATION (Filed With SEC on August 9, 2002)

Legal Proceedings (Filed With SEC on March 29, 2002)

FINANCIAL INFORMATION (Filed With SEC on August 10, 2001)

FINANCIAL INFORMATION (Filed With SEC on May 14, 2001)